Hollsteen
← MercadoLibre

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: $353M · 10-Q 0001562762-16-000383 filed May 6, 2016Equity incl. NCI · Q2 2016: $365M · 10-Q 0001562762-16-000414 filed Aug 5, 2016Equity incl. NCI · Q3 2016: $395M · 10-Q 0001562762-16-000445 filed Nov 4, 2016Equity incl. NCI · Q4 2016: $429M · 10-K 0001562762-17-000024 filed Feb 24, 2017Equity incl. NCI · Q1 2017: $482M · 10-Q 0001562762-17-000054 filed May 5, 2017Equity incl. NCI · Q2 2017: $459M · 10-Q 0001562762-17-000120 filed Aug 4, 2017Equity incl. NCI · Q3 2017: $406M · 10-Q 0001562762-17-000173 filed Nov 3, 2017Equity incl. NCI · Q4 2017: $326M · 10-K 0001562762-18-000040 filed Feb 23, 2018Equity incl. NCI · Q1 2018: $253M · 10-Q 0001562762-18-000158 filed May 10, 2018Equity incl. NCI · Q2 2018: $155M · 10-Q 0001562762-18-000229 filed Aug 9, 2018Equity incl. NCI · Q3 2018: $342M · 10-Q 0001562762-18-000323 filed Nov 2, 2018Equity incl. NCI · Q4 2018: $337M · 10-K 0001562762-19-000047 filed Feb 28, 2019Equity incl. NCI · Q1 2019: $2.2B · 10-Q 0001562762-19-000123 filed May 3, 2019Equity incl. NCI · Q2 2019: $2.1B · 10-Q 0001562762-19-000186 filed Aug 8, 2019Equity incl. NCI · Q3 2019: $2.0B · 10-Q 0001562762-19-000273 filed Nov 1, 2019Equity incl. NCI · Q4 2019: $2.0B · 10-K 0001562762-20-000055 filed Feb 14, 2020Equity incl. NCI · Q1 2020: $1.9B · 10-Q 0001562762-20-000170 filed May 6, 2020Equity incl. NCI · Q2 2020: $1.8B · 10-Q 0001562762-20-000324 filed Aug 10, 2020Equity incl. NCI · Q3 2020: $1.7B · 10-Q 0001562762-20-000390 filed Nov 5, 2020Equity incl. NCI · Q4 2020: $1.7B · 10-K 0001562762-21-000079 filed Mar 1, 2021Equity incl. NCI · Q1 2021: −$30.0M · 10-Q 0001562762-21-000200 filed May 6, 2021Equity incl. NCI · Q2 2021: $81.0M · 10-Q 0001562762-21-000313 filed Aug 5, 2021Equity incl. NCI · Q3 2021: $123M · 10-Q 0001562762-21-000420 filed Nov 5, 2021Equity incl. NCI · Q4 2021: $1.5B · 10-K 0001562762-22-000049 filed Feb 23, 2022Equity incl. NCI · Q1 2022: $1.6B · 10-Q 0001562762-22-000223 filed May 6, 2022Equity incl. NCI · Q2 2022: $1.6B · 10-Q 0001562762-22-000334 filed Aug 4, 2022Equity incl. NCI · Q3 2022: $1.6B · 10-Q 0001562762-22-000430 filed Nov 4, 2022Equity incl. NCI · Q4 2022: $1.8B · 10-K 0001099590-23-000007 filed Feb 24, 2023Equity incl. NCI · Q1 2023: $2.0B · 10-Q 0001099590-23-000013 filed May 4, 2023Equity incl. NCI · Q2 2023: $2.3B · 10-Q 0001099590-23-000020 filed Aug 3, 2023Equity incl. NCI · Q3 2023: $2.7B · 10-Q 0001099590-23-000033 filed Nov 2, 2023Equity incl. NCI · Q4 2023: $3.1B · 10-K 0001099590-24-000008 filed Feb 23, 2024Equity incl. NCI · Q1 2024: $3.4B · 10-Q 0001099590-24-000017 filed May 3, 2024Equity incl. NCI · Q2 2024: $3.7B · 10-Q 0001099590-24-000026 filed Aug 2, 2024Equity incl. NCI · Q3 2024: $4.0B · 10-Q 0001099590-24-000042 filed Nov 7, 2024Equity incl. NCI · Q4 2024: $4.4B · 10-K 0001099590-25-000007 filed Feb 21, 2025Equity incl. NCI · Q1 2025: $5.0B · 10-Q 0001099590-25-000028 filed May 8, 2025Equity incl. NCI · Q2 2025: $5.7B · 10-Q 0001099590-25-000044 filed Aug 5, 2025Equity incl. NCI · Q3 2025: $6.2B · 10-Q 0001099590-25-000051 filed Oct 30, 2025Equity incl. NCI · Q4 2025: $6.7B · 10-K 0001099590-26-000006 filed Feb 25, 2026Equity incl. NCI · Q1 2026: $7.3B · 10-Q 0001099590-26-000017 filed May 8, 2026Equity incl. NCI · Q2 2026: $7.8B · 10-Q 0001099590-26-000023 filed Aug 6, 20264597,834353Q1 2016Q2 2026Q2 2017
$MEquity incl. NCI · Q2 2016: $365M · 10-Q 0001562762-16-000414 filed Aug 5, 2016Equity incl. NCI · Q3 2016: $395M · 10-Q 0001562762-16-000445 filed Nov 4, 2016Equity incl. NCI · Q4 2016: $429M · 10-K 0001562762-17-000024 filed Feb 24, 2017Equity incl. NCI · Q1 2017: $482M · 10-Q 0001562762-17-000054 filed May 5, 2017Equity incl. NCI · Q2 2017: $459M · 10-Q 0001562762-17-000120 filed Aug 4, 2017Equity incl. NCI · Q3 2017: $406M · 10-Q 0001562762-17-000173 filed Nov 3, 2017Equity incl. NCI · Q4 2017: $326M · 10-K 0001562762-18-000040 filed Feb 23, 2018Equity incl. NCI · Q1 2018: $253M · 10-Q 0001562762-18-000158 filed May 10, 2018459253365482Q2 2016Q1 2018Q2 2017
Q2 2017
459$M
All values (42)
PeriodValue ($M)Status
Q2 20267,834reported
Q1 20267,281reported
Q4 20256,748reported
Q3 20256,218reported
Q2 20255,713reported
Q1 20255,004reported
Q4 20244,351reported
Q3 20244,002reported
Q2 20243,656reported
Q1 20243,390reported
Q4 20233,071reported
Q3 20232,741reported
Q2 20232,252reported
Q1 20232,040reported
Q4 20221,827reported
Q3 20221,631reported
Q2 20221,580reported
Q1 20221,589reported
Q4 20211,532reported
Q3 2021123reported
Q2 202181reported
Q1 2021−30reported
Q4 20201,652reported
Q3 20201,746reported
Q2 20201,808reported
Q1 20201,867reported
Q4 20191,983reported
Q3 20192,038reported
Q2 20192,146reported
Q1 20192,214reported
Q4 2018337reported
Q3 2018342reported
Q2 2018155reported
Q1 2018253reported
Q4 2017326reported
Q3 2017406reported
Q2 2017459reported
Q1 2017482reported
Q4 2016429reported
Q3 2016395reported
Q2 2016365reported
Q1 2016353reported

CSV with all sources · Technical ID: equity_total

More metrics for MercadoLibre

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$459M
Period
Q2 2017, ended Jun 30, 2017 · as of Jun 30, 2017 (balance as of date, not a sum)
Source
10-Q, filed Aug 4, 2017 · 0001562762-17-000120
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$459MAug 4, 201710-Q 0001562762-17-000120reported · confidence 1. · current